tirzepatide uric acid reduction study for maintenance of bodyweight in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide: a novel therapeutic approach

While rare, a larger hematoma may need evaluation

Clinics founded by business people often prioritize revenue over patient outcomes

Some researchers find that starting at even lower doses than the clinical trial protocols and escalating more slowly can reduce the severity of gastrointestinal symptoms

Week 14: Rapid appetite suppression + increased energy expenditure Month 13: Fastest fat loss of any studied GLP-1 class Month 36: Largest body composition shifts in trials 4872 weeks: Average 2430% total body weight reduction Ask our San Ramon team about retatrutide availability at your consultation

In the SURPASS-2 trial, patients on tirzepatide 15mg lost 13.1% body weight compared to 6.7% with semaglutidenearly double the loss

If you decide to purchase tirzepatide, it is essential to track your daily mood and energy levels to ensure your mental well-being remains a top priority during treatment